Skip to main content
Clinical Trials/NCT03073980
NCT03073980CompletedPhase 4

Assessing Efficacy of Intravenous Acetaminophen for Perioperative Pain Control for Oocyte Retrieval: a Randomized, Double Blind, Placebo-controlled Trial

Massachusetts General Hospital1 site in 1 country161 target enrollmentStarted: September 1, 2019Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
161
Locations
1
Primary Endpoint
Post-operative Pain Score Difference 10 Mins From Pre-operative

Study Overview

Brief Summary

In this research study we want to learn more about how effective certain medications are at reducing pain after oocyte (egg) retrieval surgery and how effective they are at reducing the time between the retrieval and discharge from the hospital. We will compare three types of pre-operative medications: intravenous (IV) acetaminophen, oral (PO) acetaminophen, and placebo (no medication), which is the current typical care.

Detailed Description

OBJECTIVE: To compare the efficacy of pre-operative IV acetaminophen, PO acetaminophen, versus placebo for adjunctive pain control in the setting of oocyte retrieval in an in vitro fertilization clinic setting.

HYPOTHESIS: Our hypothesis is that patients receiving IV acetaminophen pre-operatively will have improved postoperative pain scores, lower overall opiate consumption, and shortened time to discharge from post analgesic recovery unit (PACU) or recovery than those receiving PO acetaminophen or placebo.

Participants will be consented and enrolled in the study prior to their oocyte retrieval. The patient will then be randomized to one of three treatments:

Group 1: In the pre-op suite, these patients will receive 1000mg IV acetaminophen and PO placebo, followed by standard protocol anesthesia and pain control as needed.

Group 2: In the pre-op suite, these patients will receive 1000mg PO acetaminophen and IV placebo, followed by standard protocol anesthesia and pain control as needed.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 44 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • [ ] Patient is 18 years or over, undergoing oocyte retrieval. [ ] Patient is English-speaking.

Exclusion Criteria

  • [ ] Allergy/hypersensitivity to acetaminophen or opiates. [ ] Any history of liver disease, history of alcohol depending, or renal impairment as reported in the electronic health record.
  • [ ] Any history chronic opiate use or chronic pain disorder reported in the electronic health record.
  • [ ] Weight less than 50kg as reported in the medical record.

Arms & Interventions

Group 1: Intravenous (IV) acetaminophen/oral (PO) placebo

Experimental

In the pre-operative suite, these patients will receive 1000mg IV acetaminophen and PO placebo, followed by standard protocol anesthesia and pain control as needed.

Intervention: IV Acetaminophen (Drug)

Group 1: Intravenous (IV) acetaminophen/oral (PO) placebo

Experimental

In the pre-operative suite, these patients will receive 1000mg IV acetaminophen and PO placebo, followed by standard protocol anesthesia and pain control as needed.

Intervention: Placebo PO Acetaminophen (Other)

Group 2: Intravenous (IV) placebo/oral (PO) acetaminophen

Active Comparator

In the pre-op suite, these patients will receive 1000mg PO acetaminophen and IV placebo, followed by standard protocol anesthesia and pain control as needed.

Intervention: PO Acetaminophen (Drug)

Group 2: Intravenous (IV) placebo/oral (PO) acetaminophen

Active Comparator

In the pre-op suite, these patients will receive 1000mg PO acetaminophen and IV placebo, followed by standard protocol anesthesia and pain control as needed.

Intervention: Placebo IV Acetaminophen (Other)

Group 3: Oral and intravenous Placebo / Standard of care

Placebo Comparator

In the pre-op suite, these patients will receive PO and IV placebo, followed by standard protocol anesthesia and pain control as needed.

Intervention: Placebo IV Acetaminophen (Other)

Group 3: Oral and intravenous Placebo / Standard of care

Placebo Comparator

In the pre-op suite, these patients will receive PO and IV placebo, followed by standard protocol anesthesia and pain control as needed.

Intervention: Placebo PO Acetaminophen (Other)

Outcomes

Primary Outcomes

Post-operative Pain Score Difference 10 Mins From Pre-operative

Time Frame: Pain was measured pre-operatively and at 10 minutes post-procedure.

Visual analog scale of pain, ranging from 0 (no pain) to 10 (worst pain imaginable) in whole numbers. The final score is the post-operative score minus the pre-operative score.

Time to Discharge From the Post-operative Recovery Room

Time Frame: 0-6 hours post-procedure

Discharge time was based on the nurse's assessment of patient alertness, ability to tolerate oral liquids and food, and ability to void.

Secondary Outcomes

  • Procedure Length(0-2 hours)
  • Postoperative Nausea and Vomiting(0-2 days)
  • Oocyte Yield(0 days)
  • Rescue Medication Required(During procedure and immediately post-operative in recovery room within 45 minutes)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

John C Petrozza

Chief, Division of Reproductive Medicine and IVF, Principal Investigator, Clinical Professor

Massachusetts General Hospital

Study Sites (1)

Loading locations...

Similar Trials

Assessing Efficacy of Intravenous... | Clinical Trial